Patent ID: 7438722

Claim:
A method for inhibiting restenosis comprising: (a) implanting a stent at a treatment site in a patient's vasculature, wherein the stent comprises a drug-polymer layer including a first drug, therapeutic agent, medicine, compound or active agent; and (b) peri-procedurally delivering a solution comprising a second drug, therapeutic agent, medicine, compound or active agent to the treatment site intraluminally, wherein the peri-procedural deliverance of the second drug, therapeutic agent medicine, compound or active agent occurs substantially contemporaneously with, and/or immediately after, the implantation of the stent, further, wherein the solution has a viscosity of not less than 5 centipoise to prolong the residence time of the solution at the treatment site, wherein the solution further comprises a viscosifier for increasing the viscosity of the solution, and still further, wherein the solution includes (a) up to about 10 mass % of a biologically compatible water-miscible organic solvent and (b) an amount of water or aqueous buffered saline solution to prevent the second drug, therapeutic agent, medicine, compound or active agent and the viscosifier from precipitating when the composition is exposed to blood.